Navigation Links
Settlement Announced in Medtronic Qui Tam Case
Date:12/12/2011

WASHINGTON, Dec. 12, 2011 /PRNewswire/ -- Medtronic, Inc, one of the world's largest medical device manufacturers, has agreed to a $23.5m settlement with the U.S. Department of Justice (DOJ), the Office of the Inspector General for the Department of Health and Human Services, and four relators in a qui tam suit related to cardiac rhythm management devices sold by Medtronic in the U.S., including pacemakers and implantable cardioverter defibrillators (ICDs).

The settlement ends a federal qui tam suit filed in Minnesota by Sanford Wittels & Heisler, as well as a similar qui tam suit filed in California. Both suits alleged Medtronic violated the U.S. False Claims Act by using post-market studies and device registries as vehicles to pay participating physicians kickbacks for implanting its pacemakers and ICDs in Medicare or Medicaid beneficiaries.

Under today's agreement, three relators will share a settlement of some $3.8 million. The fourth relator named in the settlement will receive $160,160.

David Sanford and Grant Morris of Sanford, Wittels & Heisler represents two of the relators in the Minnesota matter.

"Our society owes an enormous debt to individuals with the courage to blow the whistle when medical device makers try to influence physicians," said Mr. Sanford. "When the use of procedures or devices is driven by corporate greed rather than medical need, it creates a potentially dangerous situation for patients and contributes to escalating medical costs."

The qui tam or whistle blower provisions of the False Claims Act permit private citizens, called "relators," to bring lawsuits on behalf of the United States and receive a portion of proceeds of any settlement or judgment. 

Mr. Morris added, "We are pleased to play a role in shining a light into this dark corner of medical device marketing. Medtronic has done the right thing by settling this matter."

Medtronic simultaneously entered into separate settlement agreements with certain states and the District of Columbia based on allegations that the company used its post-market studies and physician registries to promote the submission of similar false claims under those states' Medicaid programs.

About SWH

Sanford Wittels & Heisler is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in qui tam, employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters. In May 2010, the firm secured the largest jury award in the U.S. in a gender discrimination class action in an employment case when a jury returned a verdict of $253 million in compensatory and punitive damages against Novartis Pharmaceuticals Corporation.  For more information, contact Sanford Wittels & Heisler at (202) 742-7777.


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. K-V Pharmaceutical Company Comments on Recent Settlement With the Department of Justice
2. Kahn Swick & Foti, LLC Announces Class Action Settlement on Behalf of Purchasers of Publicly-Traded Securities of Acura Pharmaceuticals, Inc. -- ACUR
3. Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot®
4. Kremers Urban Pharmaceuticals Inc. Announces Lipitor® Settlement Agreement
5. Mylan Announces Femcon® Fe Settlement Agreement
6. Mylan Announces XELODA® Settlement and License Agreement
7. Misonix Announces Settlement of PuriCore Litigation, Including Entry into a U.S. Distribution Agreement for PuriCores Advanced Wound Care Product
8. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
9. Perrigo Announces Settlement of Cutivate Lotion Litigation
10. Par Pharmaceutical Companies Announces Settlement in Principle Regarding Certain Drug Pricing Lawsuits
11. Johnson & Johnson Announces Settlement With U.S. Department of Justice and U.S. Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):